Benchmark analyst Michael Ward maintains Lear (NYSE:LEA) with a Buy and raises the price target from $162 to $170.
Marijuana Rescheduling, Stock Market Reactions: Analyst Insights On Who Wins & Possible Trump Election
The anticipated shift of cannabis to Schedule III marks a pivotal moment for U.S. cannabis companies.